Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Pentagon missile-making plan is perplexing

Barely a month after threatening to withdraw from the Intermediate Nuclear Forces Treaty (INF), the United States has begun a program to make conventional cruise missiles. Curiously, however, there is no mention of how the country will get the components for missile parts it...
Richard (Rick) Mills | March 12, 2019 |

Will People Accept Rampant Inflation? Hell, No!

The Weekly Missive, which usually arrives over the weekend (sometimes on Friday, sometimes on Sunday) was delayed this weekend for one reason: I had to change it. I started out last week with an idea that was leaning in the direction of full-on capitulation in the sen...
Streetwise Reports | June 24, 2020 |

ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results

Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. After the U.S. markets closed yesterday, ChemoCentryx Inc. ...
Streetwise Reports | November 27, 2019 |

America the Broken – Can It Be Restored?

This is the first issue of The Rise of America , a series about the future of the United States as the global superpower. You’ll read about the forces that will propel it to unprecedented dominance—and how you can best position yourself to profit fr...
Marin Katusa | March 27, 2020 |

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...
Marc Davis | April 22, 2021 |

The growing weaponization of space

In his recent State of the Union address, President Trump gave a shout-out to space exploration, highlighting the newly-created Space Force branch of the US Military, and NASA’s Artemis program of crewed lunar exploration. Artemis aims to put astronauts on ...
Richard (Rick) Mills | February 14, 2020 |

The Mirage Called 'Modern Monetary Theory'

I was poring over the Federal Reserve minutes from Feb. 21, and as I was rolling my eyes and looking around my den for something to throw, I was reminded of the comments from then-Fed chairman Ben Bernanke years ago when he was asked if the Fed was "monetizing debt." The ...
Streetwise Reports | February 26, 2019 |

Quadruple-Witching Leading into Saint Paddy's Day

I was sitting in our local Port Perry pub this week when I overheard a couple of the local senior citizens discussing the upcoming arrival of the Saint Patrick's Day celebration where everybody dons a green shirt or a green tie or a green glass of beer and announces to th...
Streetwise Reports | March 18, 2019 |